In this episode we talk to Dr Stephen Bradley about the variation in the use of CXRs between practices and the implications for early diagnosis of lung cancer.
We talk to Dr Christos Grigoroglou and Professor Kieran Walshe about some of the findings, not all expected, from a study exploring the use of locums in England.
Dr Anita Lim talks about a trial that found offering older women non-speculum sampling with their clinician can improve uptake for cervical screening.
Dr Jordan Moxey and Dr Carol Sinnott come on the podcast to tell us about research that directly observed what consumes GPs’ time and what disrupts their ability to complete tasks.
Professor Helen Snooks tells us about a study exploring why a risk prediction tool (PRISM) in general practice actually increased emergency and hospital admissions and we discuss the importance of evaluating interventions before they are introduced as policy.
Dr Lucy Martin tells us about her research into mid-career resilience. Resilience is often discussed and, as a concept, it is not generally well understood but with GPs under severe pressure it is now more important than ever for us to explore
Dr Patrick Highton talks us through a RCT that promoted physical activity in people with multimorbidity. Unfortunately, no benefit was seen and we discuss the challenges of trials and future avenues to explore.
This study examined whether GP continuity of care matters and 4.5 million Norwegian patients and their named GPs were included. There is a strong association between continuity and patient outcomes including hospitalisations and mortality.
Dr Thomas Round talks about research that shows how 2-week wait referrals for cancer have more than doubled up to 2018/2019.
Professor Stewart Mercer talks about how the implementation of social prescribing via a link worker programme has worked in Deep End practices in Glasgow and offers his expert thoughts on the evidence base in this area, the inverse care law and addressing
This study gives insights into how GPs document safety-netting advice and how it compares to what actually happened in the consultation.
We speak to Dr Faraz Mughal about young people who self-harm and how we can improve primary care services for them.
We speak to Dr Ian Bennett-Briton about a system of continuous risk-based peer review and how GPs found it.
We speak to Dr Julian Treadwell about how GPs talk to patients about numbers and how we feel about discussing risks and benefits.
We speak to Dr Marta Wanat about a study that explored the experiences of primary care across eight European countries during the first wave of COVID-19.
Erin Oldenhof and Dr Petra Staiger join us from Australia to offer practical, actionable advice from their paper to support prescribers in discontinuing benzodiazepines.
Dr Felicity Knights talks to us about new research on the impact of COVID-19 and migrant health and how we can make primary care more accessible.
Dr Elizabeth Cecil joins us to talk about research exploring the factors associated with potentially missed acute deterioration in primary care.
Remco Tuijt from the UCL Research Department of Primary Care and Population Health talks us through a qualitative paper exploring the experiences of remote consultations for people living with dementia and their carers.
Dr Jean-Pierre Laake and Prof Willie Hamilton join us to talk about a randomised controlled trial that targeted groups to encourage them to attend for possible cancer-related symptoms.
Dr Riitta Partanen joins us to tell us more about a study looking at GPs' insight into discontinuing long-term antidepressants.
Professor Sir Michael Marmot talks about Julian Tudor Hart and the role of GPs "natural allies" in his work to tackle social determinants of health.
Dr Claire Friedemann Smith talks about a qualitative study that explores how GPs use gut feelings to help them navigate grey areas in diagnosis.
Professor Jane Gunn discusses research into a self-administered tool for depression. This RCT showed that 'Target-D', a person-centred clinical prediction tool and e-health platform matching management options to prognosis, results in greater improvement in depressive symptoms at 3 months than usual care.
Professor Jane Gunn talks about a randomised controlled trial, Target-D, that aims to match the best treatment to people with depression.